Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05200325 · ClinicalTrials.gov registry record · NA
Clinical Utility Evidence for TissueCypher®
A NA study, sponsored by Qure Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 280
- Enrollment target
NCT05200325 is a NA study that has completed, run by Qure Healthcare. The registered enrollment target is 280 participants.
The verdict
NCT05200325, a NA study, has completed, sponsored by Qure Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 280 participants
- Enrollment target
Study Summary
Cernostics has developed a new diagnostic test, and this study will measure how gastroenterologists and foregut surgeons make diagnostic and treatment decisions when presented with different information in the context of simulated clinical cases. The results of this study could contribute to improved quality of care for patients by encouraging better care practices and adherence to evidence-based guidance. The data from this study will be provided to all participating physicians and submitted to a national journal for publication. The study plans to enroll up to 249 physicians.
Interventions
- OTHER Educational materials for TissueCypher
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2021-06-06 |
| Est. Completion | 2021-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05200325
The ClinicalTrials.gov registry entry for NCT05200325 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 280 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Qure Healthcare, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Educational materials for TissueCypher is the first listed.
NCT05200325 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05200325 about?
NCT05200325 is a clinical study titled "Clinical Utility Evidence for TissueCypher®". Cernostics has developed a new diagnostic test, and this study will measure how gastroenterologists and foregut surgeons make diagnostic and treatment decisions when presented with different information in the context of simulated clinical cases. The results of this study could contribute to improve...
What is the current status of trial NCT05200325?
This trial is currently completed. It is a NA study. The enrollment target is 280 participants. The study started on 2021-06-06. Estimated completion is 2021-12-15.
What interventions are being tested in trial NCT05200325?
The interventions under investigation include: Educational materials for TissueCypher (OTHER).
Who is sponsoring clinical trial NCT05200325?
This trial is sponsored by Qure Healthcare, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.